Bevacizumab and Retinal Vascular Occlusions

Phase 3WithdrawnNCT00347711

Asociación para Evitar la Ceguera en México

Overview

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Masking

NONE

Conditions

Edema Macular Vascular Occlusion

Interventions

Intravitreal injectionDRUG

Eligibility

Sex: ALLMin age: 40 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography Exclusion Criteria: * Previous surgery * Uveitis * Glaucoma

Locations (1)

Asociacion para Evitar la Ceguera en Mexico

México, D.F. Mexico, Mexico

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.